First round of Abstract Submissions is open now..!
Don't miss the opportunity! Submit your abstract for the first round by November 28, 2025.
First round of Abstract Submissions is open now..!
Don't miss the opportunity! Submit your abstract for the first round by November 28, 2025.
Precision Oncology is a medical approach that uses genomic information to guide treatment, and it is the foundation for targeted cancer therapies, which are drugs designed to attack specific molecules driving cancer growth. Instead of broad chemotherapy, precision oncology matches an individual's tumor to a specific therapy, which aims to be more effective and cause fewer side effects. This involves testing for specific genetic mutations, proteins, or other biomarkers in a patient's tumor to identify which targeted therapy will be most effective.